Clinical Trial

Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine Cancer

Study acronym: MICHELE
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this phase III clinical trial, is to evaluate the efficacy and safety of concomitant chemo-radiotherapy with Cisplatin vs Gemcitabine as the first line of treatment in patients with locally advanced cervical cancer, with comorbidities and preserved renal function.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-11-27; most recent amendment 2025-05-22.
Trial Details
NCT Number NCT06156514
Lead Sponsor National Institute of Cancerología
Conditions Locally Advanced Cervical Cancer, Gemcitabine, Chemo-radiotherapy
Enrollment 140 participants
Start Date 2019-11-06
Primary Completion 2026-11-30 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-28